Previous Article | Next Article ![]()
Mol Cell Biol, July 1998, p. 3681-3691, Vol. 18, No. 7
Institute for Biochemistry and Molecular Cell
Biology and Ludwig Boltzmann Forschungsstelle, University of
Vienna, Vienna, Austria,1 and
Rockefeller University, New York, New York
100212
Received 20 November 1997/Returned for modification 23 December
1997/Accepted 30 March 1998
In yeast, the pheromone
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Pheromone-Dependent G1 Cell Cycle
Arrest Requires Far1 Phosphorylation, but May Not Involve
Inhibition of Cdc28-Cln2 Kinase, In Vivo
,1
-factor acts as an antiproliferative
factor that induces G1 arrest and cellular differentiation. Previous data have indicated that Far1, a factor dedicated to pheromone-induced cell cycle arrest, is under positive and negative posttranslational regulation. Phosphorylation by the
pheromone-stimulated mitogen-activated protein (MAP) kinase Fus3 has
been thought to enhance the binding of Far1 to G1-specific
cyclin-dependent kinase (Cdk) complexes, thereby inhibiting their
catalytic activity. Cdk-dependent phosphorylation events were invoked
to account for the high instability of Far1 outside early
G1 phase. To confirm any functional role of Far1
phosphorylation, we undertook a systematic mutational analysis of
potential MAP kinase and Cdk recognition motifs. Two putative
phosphorylation sites that strongly affect Far1 behavior were
identified. A change of serine 87 to alanine prevents the cell
cycle-dependent degradation of Far1, causing enhanced sensitivity to
pheromone. In contrast, threonine 306 seems to be an important
recipient of an activating modification, as substitutions at this
position abolish the G1 arrest function of Far1. Only the
phosphorylated wild-type Far1 protein, not the T306-to-A substitution
product, can be found in stable association with the Cdc28-Cln2
complex. Surprisingly, Far1-associated Cdc28-Cln2 complexes are at best
moderately inhibited in immunoprecipitation kinase assays, suggesting
unconventional inhibitory mechanisms of Far1.
*
Corresponding author. Present address: Cold Spring
Harbor Laboratory, P.O. Box 100, Cold Spring Harbor, N.Y. Phone: (516) 367-8385. Fax: (516) 367-8461. E-mail: gartner{at}cshl.org.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|